Series by David C. Helfgott, MD
A collection of news, case studies, and feature articles focused on the diagnosis and management of infectious processes in patients with immune systems impaired by an underlying disease, such as hematologic malignancies that affect cells crucial to normal host immune response, or weakened secondary to treatments for disease, such as steroids, chemotherapeutic agents, or biologic response modifiers targeting immune mediators.
In this review, David C. Helfgott, MD, editorial advisory board member for Infectious Disease Advisor, focuses on infectious complications from the use of monoclonal antibodies for malignancy.
The risk for infection and malignancy associated with biologic use complicates the management of patients with a deficient immune system. Equip yourself with the information needed to effectively manage these complex patients.
September 15, 2017
Case of a 51-year-old man with Crohn's disease who develops fever and cough after receiving biologic treatment.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Homeopathy No Better Than Placebo for Respiratory Infections in Children
- CDC Director Says Congo Ebola Outbreak May Be Uncontainable
- Many Linens Delivered To US Hospitals Contaminated With Mucorales Mold
- Depression and Alcohol Misuse Lower Odds of Achieving Viral Suppression in HIV
- Low Rates of HBsAg Seroclearance in Chronic HBV Infection
- Oral Urinary Tract Infection Treatments
- Treating Pseudomonas aeruginosa Infections: Highlights From IDWeek 2018
- Local Gentamicin Application Ineffective in Treatment of Periprosthetic Joint Infection
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Social Medicine: The Effect of Social Media on the Anti-Vaccine Movement
- The Effect of Chronic Pain on HIV Outcomes
- Entecavir, Peginterferon Ineffective for Immune-Tolerant Hepatitis B in Children
- Update on the Ethics of Mandating HPV Vaccination
- Hands Are Vehicles for Transmission of Streptococcus pneumoniae
- Certain Iron Deficiencies May Protect Against Malaria in African Children